R-EPOCH regimen: Difference between revisions
Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}} ==Overview== {{PAGENAME}} refers to a regimen consisting of xxx used to treat Hodgkin's lymphoma. ==Regimen== {{chemo|x|x..." |
No edit summary |
||
| Line 19: | Line 19: | ||
==Indications== | ==Indications== | ||
* [[Hodgkin's lymphoma|Hodgkin's lymphoma, nodular lymphocyte-predominant]] | * [[Hodgkin's lymphoma|Hodgkin's lymphoma, nodular lymphocyte-predominant]] | ||
* [[HIV]]-associated [[lymphoma]] | |||
==References== | ==References== | ||
Revision as of 18:02, 31 March 2015
|
WikiDoc Resources for R-EPOCH regimen |
|
Articles |
|---|
|
Most recent articles on R-EPOCH regimen Most cited articles on R-EPOCH regimen |
|
Media |
|
Powerpoint slides on R-EPOCH regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on R-EPOCH regimen at Clinical Trials.gov Trial results on R-EPOCH regimen Clinical Trials on R-EPOCH regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on R-EPOCH regimen NICE Guidance on R-EPOCH regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on R-EPOCH regimen Discussion groups on R-EPOCH regimen Patient Handouts on R-EPOCH regimen Directions to Hospitals Treating R-EPOCH regimen Risk calculators and risk factors for R-EPOCH regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for R-EPOCH regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:
Overview
R-EPOCH regimen refers to a regimen consisting of xxx used to treat Hodgkin's lymphoma.
Regimen
xxx
xxx
xxx
xxx